Neural Therapy: Autonomic Reset, Interference Fields & Procaine Injection Protocols

What Is Neural Therapy?

Neural therapy is a therapeutic system developed in Germany in the early 20th century that uses injections of local anesthetics — most commonly procaine (Novocain) — into specific anatomical sites to reset pathological electrical signals in the autonomic nervous system, resolve chronic pain, and eliminate so-called "interference fields" (Störfelder) that are believed to maintain dysfunction throughout the body.

Rooted in the neurophysiology of the autonomic nervous system and the work of physicians Ferdinand and Walter Huneke (who discovered the phenomenon in 1940), neural therapy is widely practiced in Germany, Switzerland, Austria, and Latin America, and is gaining recognition in integrative medicine practices globally. It operates at the intersection of neurology, pain medicine, and regulatory medicine — addressing not just local pathology but the systemic autonomic dysregulation that perpetuates chronic illness.

The Theoretical Foundations of Neural Therapy

The Autonomic Nervous System as Master Regulator

The autonomic nervous system (ANS) — comprising sympathetic, parasympathetic, and enteric divisions — regulates virtually every organ system: heart rate, blood pressure, digestive motility, immune activation, hormonal secretion, and tissue repair. In health, the ANS responds dynamically to internal and external stimuli, self-correcting within seconds to minutes.

In chronic disease, traumatic injury, surgery, infection, or emotional stress can produce persistent sympathetic hyperactivation — a state of autonomic "lock" in which the nervous system fails to return to regulatory balance. Neural therapy proposes that this dysregulation is maintained by focal areas of abnormal electrical activity: the interference fields.

Interference Fields (Störfelder)

An interference field is any area of the body that generates an abnormal, sustained bioelectric signal capable of disrupting autonomic regulation systemically — not just locally. Common sources include:

• Surgical scars (especially abdominal, pelvic, dental, and thoracic)
• Dental foci (root canals, cavitations, amalgam restorations, extracted tooth sockets)
• Chronically inflamed or infected tonsils, sinuses, or appendix
• Old fractures, trauma sites, and joint injuries
• Vaccination sites and injection scars
• Emotional trauma encoded as somatic patterns (psychosomatic interference)

The Huneke brothers documented cases where injection of procaine into a remote scar — distant from the presenting complaint — produced immediate, dramatic resolution of chronic symptoms. This "lightning reaction" (Sekundenphänomen) — lasting relief within seconds of injection — became the defining clinical phenomenon of neural therapy and a key diagnostic criterion for identifying active interference fields.

Procaine: Why This Specific Anesthetic?

Procaine (not lidocaine or other amides) is the agent of choice in classical neural therapy for several reasons beyond its local anesthetic properties:

• Membrane stabilization: Procaine restores normal resting membrane potential in cells with pathologically depolarized membranes — the proposed mechanism of interference field resolution.
• Autonomic reset: Procaine directly affects sympathetic ganglia, interrupting sustained sympathetic discharge and allowing parasympathetic tone to re-emerge.
• Anti-inflammatory properties: Procaine inhibits prostaglandin synthesis and stabilizes mast cells — reducing local neurogenic inflammation.
• Antioxidant activity: The metabolite para-aminobenzoic acid (PABA) has antioxidant and mitochondrial protective properties.
• Short duration: Procaine's brief action (30–60 minutes local anesthesia) means its therapeutic benefit outlasts its pharmacological effect — consistent with a regulatory/reset mechanism rather than simple anesthesia.

Lidocaine and bupivacaine are sometimes used as substitutes but are generally considered inferior in the neural therapy tradition due to different pharmacological profiles and lack of the procaine-specific metabolite pathway.

Injection Sites & Techniques

1. Segmental Neural Therapy

Segmental injections target dermatomes, myotomes, and sclerotomes corresponding to the affected organ or pain region. Common segmental techniques include:

• Intracutaneous wheals: Superficial intradermal injections creating a small bleb of procaine — stimulating cutaneous autonomic nerve endings and producing reflex effects on underlying organs via the somatovisceral axis.
• Trigger point injections: Procaine into myofascial trigger points releases sustained muscle contracture and associated sympathetic hyperactivation.
• Periosteal injections: Into the periosteum of bones and joints for orthopedic pain with autonomic components.
• Neural point injections: Along peripheral nerve pathways, at nerve foramina, or at neurovascular bundles.

2. Ganglion Injections

Autonomic ganglia are key targets in neural therapy, providing direct access to the sympathetic chain:

• Stellate ganglion block (SGB): Injection at the cervicothoracic ganglion (C6–T1 level). Resets sympathetic outflow to the head, neck, upper extremities, heart, and lungs. Used for PTSD, hot flashes, cardiac arrhythmia, complex regional pain syndrome (CRPS), and tinnitus. Military and VA research has documented PTSD symptom reduction following SGB (Lipov et al.; Hollifield et al., 2019 RCT).
• Celiac plexus block: Targets the solar plexus — the major sympathetic ganglion of the abdomen. Used for chronic abdominal pain, visceral hypersensitivity, pancreatitis, and as adjunct in GI autonomic dysfunction.
• Superior cervical ganglion: Addresses head, face, and intracranial autonomic dysregulation.
• Lumbar sympathetic chain: Lower extremity CRPS, peripheral vascular disease, and pelvic pain syndromes.
• Sphenopalatine ganglion (SPG): Via transnasal approach; used for cluster headaches, migraines, facial pain, and trigeminal neuralgia.

3. Scar Injections

Scar tissue — particularly from surgeries, trauma, or burns — is among the most common and underappreciated interference fields. Procaine is injected intradermally along the full length of the scar, with multiple small wheals placed at 1–2 cm intervals. Scars that appear well-healed cosmetically can maintain active autonomic interference for decades. Common high-impact scar sites:

• Abdominal/cesarean scars (associated with pelvic floor dysfunction, GI dysregulation)
• Thyroid/neck scars (vagal interference, thyroid dysfunction)
• Appendectomy and cholecystectomy scars
• Breast surgery and mastectomy scars
• Dental extraction sites and root canal teeth

4. Dental Neural Therapy

The oral cavity is one of the most neurologically dense and autonomically influential regions of the body. Dental interference fields — root canals, cavitations (ischemic osteonecrosis of the jaw), amalgam restorations, and infected extraction sockets — are disproportionately represented as causative factors in refractory chronic illness, including autoimmune conditions, chronic fatigue, and neurological dysfunction. Neural therapy at dental foci often requires collaboration with a biological dentist for definitive treatment (cavitation surgery, safe amalgam removal) alongside procaine injections for autonomic reset.

Clinical Indications

Pain Conditions

• Complex regional pain syndrome (CRPS I and II)
• Fibromyalgia and widespread myofascial pain
• Chronic headache and migraine
• Trigeminal neuralgia and facial pain
• Cervicogenic pain and whiplash sequelae
• Chronic back and pelvic pain
• Post-surgical and post-traumatic pain

Autonomic & Systemic Conditions

• POTS and dysautonomia
• PTSD and trauma-mediated autonomic dysregulation (SGB)
• Irritable bowel syndrome and visceral hypersensitivity
• Interstitial cystitis and pelvic floor dysfunction
• Chronic sinusitis and ENT conditions with autonomic components
• Tinnitus and vertigo
• Cardiac arrhythmia with sympathetic excess
• Hot flashes and menopausal vasomotor symptoms (SGB)

Chronic Illness & Unresolved Cases

Neural therapy is particularly valuable in cases where conventional medicine has failed to identify a clear diagnosis or produce lasting benefit — often because the underlying driver is an interference field maintaining systemic autonomic dysregulation. Conditions frequently found to have active interference fields include:

• Chronic Lyme disease and post-infectious syndromes
• Post-COVID autonomic dysfunction (long COVID)
• Autoimmune conditions with unresolved triggers
• Chronic fatigue syndrome / ME-CFS
• Thyroid dysfunction unresponsive to hormone replacement

The Neural Therapy Diagnostic Approach

Neural therapy diagnosis relies on a detailed history — cataloguing all scars, surgeries, dental procedures, infections, accidents, and significant emotional events — combined with physical examination of autonomic tone (heart rate variability, skin conductance, vascular patterns) and targeted injection to identify active interference fields.

The lightning reaction (Sekundenphänomen) — immediate and dramatic symptom resolution within seconds of procaine injection at an interference field site — serves as both diagnostic confirmation and therapeutic response. It is a reliable, reproducible phenomenon when correctly identified and is considered pathognomonic for an active interference field.

A full neural therapy workup typically requires multiple sessions — each injection round addressing potential interference fields systematically until the causative focus is identified and resolved.

Safety & Contraindications

Safety Profile

Neural therapy has an excellent safety record in experienced hands. Procaine is one of the safest local anesthetics — rapidly metabolized by plasma pseudocholinesterase to PABA and diethylaminoethanol, with minimal systemic toxicity at the doses used.

Precautions

• Procaine allergy: True allergy to procaine (ester-type anesthetic) is rare; most reported reactions are vasovagal or preservative-related. Cross-reactivity with sulfonamides exists via the PABA metabolite.
• Pseudocholinesterase deficiency: Rare genetic condition impairing procaine metabolism; testing warranted in patients with personal or family history of anesthetic complications.
• Anticoagulant therapy: Deep ganglion injections require careful risk assessment in patients on anticoagulants.
• Pneumothorax risk: Stellate ganglion and thoracic injections require precise technique and ideally ultrasound guidance.
• Infection: Standard aseptic technique mandatory; injection through infected tissue is contraindicated.

Integration with Other Modalities

Neural therapy is rarely used in isolation in modern integrative practice. Effective combinations include:

• Vagus nerve stimulation + neural therapy: SGB and segmental cervical injections complement vagal toning protocols for autonomic rebalancing. See: Vagus Nerve Stimulation & Nervous System Repair.
• Acupuncture + neural therapy: Acupuncture meridian points and neural therapy segmental points overlap substantially — combined protocols address both energetic and neurophysiological dimensions. See: Acupuncture & Traditional Chinese Medicine.
• PEMF + neural therapy: PEMF applied post-injection enhances tissue conductivity and sustains autonomic reset. See: PEMF Therapy: A Complete Deep-Dive Guide.
• IV nutrient therapy + neural therapy: IV magnesium, B vitamins, and glutathione support neurological repair and reduce sympathetic hyperactivation between neural therapy sessions. See: IV Nutrient Therapy: Myers Cocktail, Glutathione, NAD+ & Beyond.
• Mind-body medicine + neural therapy: Trauma-encoded interference fields have both somatic and psychological components — neural therapy addresses the neurophysiological substrate while somatic therapies, EMDR, and breathwork address the psychological layer. See: Mind-Body Medicine for Chronic Pain.

Clinical Evidence & Research

• Stellate ganglion block for PTSD: Hollifield M et al. "Stellate Ganglion Block for PTSD: A Randomized, Double-Blind, Controlled Trial." Depress Anxiety. 2019;36(8):689–701.
• SGB for hot flashes: Lipov EG et al. "Effects of stellate-ganglion block on hot flushes and night awakenings in survivors of breast cancer." Lancet Oncol. 2008;9(6):523–532.
• Neural therapy systematic review: Barop H. "Textbook and Atlas of Neural Therapy." Stuttgart: Hippokrates Verlag, 2012. (Foundational German-language reference.)
• Procaine mechanisms: Dosch P. "Manual of Neural Therapy According to Huneke." Heidelberg: Haug Publishers, 1984.
• Sphenopalatine ganglion block for migraine: Robbins MS et al. "The Sphenopalatine Ganglion: Anatomy, Pathophysiology, and Therapeutic Targeting in Headache." Headache. 2016;56(2):240–258.

Key Takeaways

• Neural therapy uses procaine injections to reset pathological autonomic nervous system states and resolve interference fields — focal areas of abnormal bioelectric activity that maintain systemic dysfunction.
• Common interference field sources include surgical scars, dental foci (root canals, cavitations), old trauma sites, and tonsillar or sinus foci.
• The lightning reaction (Sekundenphänomen) — immediate symptom resolution upon procaine injection — is the hallmark diagnostic and therapeutic response.
• Key injection targets include scars, trigger points, autonomic ganglia (stellate, celiac, lumbar sympathetic, sphenopalatine), and segmental dermatomes.
• Strong evidence supports stellate ganglion block for PTSD, hot flashes, and cardiac arrhythmia; broader neural therapy applications are supported by extensive clinical tradition and case documentation.
• Most effective when integrated with vagus nerve work, acupuncture, PEMF, IV nutrients, and trauma-informed psychosomatic approaches.

Acknowledgements

This article draws on the foundational clinical and academic contributions of Ferdinand and Walter Huneke (discoverers of the interference field phenomenon), Peter Dosch, MD (Manual of Neural Therapy), and Henning Barop, MD (Textbook and Atlas of Neural Therapy), whose systematic documentation of neural therapy principles and techniques established the clinical framework referenced throughout. Research on stellate ganglion block is cited from peer-reviewed publications in Depress Anxiety and Lancet Oncology.